ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,787Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 625

$888K Total Retail Price of All Prescriptions

Rank: 42 out of 625

777 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 777 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 777 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,917 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 1,494 592 S3 1 4
SIMVASTATIN 532 392 2 2
OMEPRAZOLE 522 298 3 6
TRAMADOL HCL 471 220 4 16
AMLODIPINE BESYLATE 464 327 5 1
LISINOPRIL 449 286 6 5
PRAVASTATIN SODIUM 409 227 7 8
METOPROLOL TARTRATE 388 263 8 11
LEVOTHYROXINE SODIUM 367 284 9 3
GABAPENTIN 359 177 10 14
FUROSEMIDE 336 226 11 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 300 183 12 27
METFORMIN HCL ER 281 152 13 41
ZOLPIDEM TARTRATE 278 151 14 13
CITALOPRAM HBR 233 135 15 24
HYDROCHLOROTHIAZIDE 214 148 16 12
POTASSIUM CHLORIDE 200 132 17 19
DONEPEZIL HCL 193 154 18 33
ATORVASTATIN CALCIUM 193 127 18 9
GLIMEPIRIDE 193 109 18 42
RANITIDINE HCL 188 112 21 25
NEXIUM 182 97 22 21
LOSARTAN POTASSIUM 182 127 22 18
WARFARIN SODIUM 165 121 24 20
CARVEDILOL 154 95 25 23
METFORMIN HCL 152 48 26 10
SERTRALINE HCL 149 108 27 26
VENLAFAXINE HCL ER 148 52 28 86
MELOXICAM 147 69 29 31
TAMSULOSIN HCL 138 103 30 36
DIVALPROEX SODIUM 136 115 31 91
PANTOPRAZOLE SODIUM 134 49 32 44
TRAZODONE HCL 130 33 33 51
LOSARTAN-HYDROCHLOROTHIAZIDE 130 115 33 38
CYMBALTA 129 38 35 46
CLONIDINE HCL 127 65 36 50
METOPROLOL SUCCINATE 123 91 37 15
ATENOLOL 122 91 38 22
FENOFIBRATE 109 22 39 59
NAMENDA 106 91 40 45
ROPINIROLE HCL 101 70 41 96
PROMETHAZINE HCL 99 33 R 42 84
AMITRIPTYLINE HCL 97 48 R 43 61
PROAIR HFA 96 36 44 57
CARISOPRODOL 96 0 R 44 89
CYCLOBENZAPRINE HCL 94 17 R 46 65
MORPHINE SULFATE ER 94 22 S2 46 145
TRIAMTERENE-HCTZ 93 39 48 53
AMLODIPINE BESYLATE-BENAZEPRIL 92 71 49 48
FLUTICASONE PROPIONATE 89 31 50 32
SPIRIVA 89 54 50 70
MIRTAZAPINE 88 70 52 69
CELEBREX 85 43 53 72
CEFUROXIME 84 43 54 161
CLOPIDOGREL 82 48 55 30
PLAVIX 82 44 55 43
SPIRONOLACTONE 82 41 55 64
FINASTERIDE 79 48 58 139
OXYCODONE HCL 75 21 S2 59 79
TIZANIDINE HCL 75 13 59 115
CIPROFLOXACIN HCL 72 42 61 60
ESTRADIOL 71 34 R 62 128
LYRICA 70 23 63 71
MECLIZINE HCL 69 46 64 113
BENAZEPRIL HCL 69 30 64 35
ACTOS 65 45 66 102
PREDNISONE 64 34 67 37
ALPRAZOLAM 64 18 67 215
KLOR-CON 10 64 54 67 134
VENTOLIN HFA 63 36 70 93
ALENDRONATE SODIUM 62 60 71 34
SINGULAIR 60 27 72 94
SYMBICORT 57 18 73 123
RISPERIDONE 54 32 74 92
NORTRIPTYLINE HCL 54 21 74 247
LOVASTATIN 54 27 74 58
AZITHROMYCIN 51 22 77 40
ALLOPURINOL 51 36 77 29
FLUOXETINE HCL 50 27 79 62
KLOR-CON M20 50 16 79 47
OXYCODONE HCL-ACETAMINOPHEN 50 0 S2 79 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.